Breaking Finance News

Ventas, Inc. (NYSE:VTR) has been downgraded to Buy in a statement by BidaskClub earlier today.

BidaskClub has downgraded Ventas, Inc. (NYSE:VTR) to Buy in a statement released on Saturday July 08, 2017.

Having a price of $67.47, Ventas, Inc. (NYSE:VTR) traded 0.23% higher on the day. With the last close up -0.47% from the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the same period. Ventas, Inc. has recorded a 50-day average of $67.88 and a two hundred day average of $65.25. Volume of trade was down over the average, with 1,222,611 shares of VTR changing hands under the typical 1,613,490

Performance Chart

Ventas, Inc. (NYSE:VTR)

With a total market value of $0, Ventas, Inc. has price-earnings ratio of 32.90 with a one year low of $56.20 and a one year high of $74.67 .

A total of 13 analysts have released a research note on Ventas, Inc.. One analyst rating the company a strong buy, two analysts rating the company a buy, eleven analysts rating the company a hold, one analyst rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $62.54.

More About Ventas, Inc. (NYSE:VTR)

Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.